Faeth Therapeutics, Inc. (FTH)
NCM · Healthcare · Biotechnology
$20.10
-2.28%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$519.4M
Shares Outstanding
25.8M
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (4.9M) | (5.0M) | (170.6M) | (18.4M) |
| Net Income | (4.6M) | (4.7M) | (170.2M) | (16.0M) |
| Diluted EPS | $-3.62 | N/A | $-131.45 | $-2.84 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (50.2M) | (37.1M) | (31.7M) | (22.3M) |
| Net Income | (48.6M) | (34.1M) | (30.2M) | (21.1M) |
| Diluted EPS | $-31.60 | $-24.40 | $-24.00 | $-16.72 |